KN 015

Drug Profile

KN 015

Alternative Names: KN-015

Latest Information Update: 30 Jun 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Alphamab
  • Class Infertility therapies
  • Mechanism of Action Follicle stimulating hormone modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I Infertility

Most Recent Events

  • 01 Jun 2017 Phase-I clinical trials in Infertility (In volunteers) in China (SC) (NCT03192527)
  • 01 Jun 2017 Preclinical trials in Infertility in China (SC)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top